# U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-ai-24-023-u-s-south-africa-program-for-collaborative-biomedical/  
Official notice: https://www.grants.gov/search-results-detail/356439

> National Institutes of Health offered grants of up to $400,000 to the applicants described in the notice. Applications closed on March 12, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-24-023 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | March 12, 2025 |
| Award ceiling | $400,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.242, 93.273, 93.310, 93.393, 93.399, 93.855, 93.865 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); See funding opportunity for eligibility criteria. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

## What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to support research projects under Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. Research areas supported under this program include HIV/AIDS, HIV/AIDS co-morbidities and co-infections, HIV/AIDS-associated implementation science, and HIV/AIDS-associated data science. The hallmark of the U.S.-South Africa program is the development of collaborative partnerships between South African investigators and United States (U.S.) investigators. Through international collaboration, this research will advance scientific discoveries, promote sharing of technologies and approaches, and serve local public health needs and priorities in support of global HIV/AIDS research.

## Questions people ask

### Is RFA-AI-24-023 still open?

No. It closed on March 12, 2025.

### Who can apply for U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)?

National Institutes of Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)?

Closed March 12, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $400,000 each.

### Who has won Mental Health Research Grants grants before?

The largest recipients over five fiscal years were Yale Univ, University of Pittsburgh - of the Commonwealth System of Higher Education, University of California, Los Angeles. The program made 6,785 awards worth $8.8 billion in that time.